Abstract
To determine whether genotoxic and non-genotoxic carcinogens contribute similarly to the cancer burden in humans, an analysis was performed on agents that were evaluated in Supplements 6 and 7 to the IARC Monographs for their carcinogenic effects in humans and animals and for the activity in short-term genotoxicity tests.
The prevalence of genotoxic carcinogens on four groups of agents, consisting of established human carcinogens (group 1, n = 30), probable human carcinogens (group 2A, n = 37), possible human carcinogens (group 2B, n = 113) and on agents with limited evidence of carcinogenicity in animals (a subset of group 3, n = 149) was determined.
A high prevalence in the order of 80 to 90% of genotoxic carcinogens was found in each of the groups 1, 2A and 2B, which were also shown to be multi-species/multi-tissues carcinogens.
The distribution of carcinogenic potency in rodents did not reveal any specific characteristic of the human carcinogens in group 1 that would differentiate them from agents in groups 2A, 2B and 3.
The results of this analysis indicate that (a) an agent with unknown carcinogenic potential showing sufficient evidence of activity in in vitro / in vivo genotoxicity assays (involving as endpoints DNA damage and chromosomal/mutational damage) may represent a hazard to humans; and (b) an agent showing lack of activity in this spectrum of genotoxicity assays should undergo evaluation for carcinogenicity by rodent bioassay, in view of the present lack of validated short-term tests for non-genotoxic carcinogens.
Overall, this analysis implies that genotoxic carcinogens add more to the cancer burden in man than non-genotoxic carcinogens. Thus, identification of such genotoxic carcinogens and subsequent lowering of exposure will remain the main goal for primary cancer prevention in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ASHBY, J. and TENNANT, R.W. (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat. Res., 204:7–115.
BROCKMAN, H.E. and DeMARINI, D.M. (1988). Utility of short-term tests for genetic toxicity in the aftermath of the NTP's analysis of 73 chemicals. Environ. Mol. Mutagenesis, 11:421–435.
GOLD, L.S., SAWYER, C.B., MAGAW, R., BACKMAN, G.M., de VECIANA, M., LEVINSON, R., HOOPER, N.K., HAVENDER, W.R., BERNSTEIN, L., PETO, R., PIKE, M.C. and AMES, B.N. (1984). A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect., 58:9–319.
HEDDLE, J.A. (1988). Discussion forum. Prediction of chemical carcinogenicity from in vitro genetic toxicity. Mutagenesis, 3(4):287–291.
IARC MONOGRAPHS on the EVALUATION of CARCINOGENIC RISKS to HUMANS. (1987). Supplement 6. Genetic and Related Effects: An Updating of Selected IARC Monographs from Volumes 1 to 42, Lyon: IARC.
IARC MONOGRAPHS on the EVALUATION of CARCINOGENIC RISKS to HUMANS. (1987). Supplement 7. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. Volumes 1 to 42, Lyon: IARC.
KALDOR, J.M., DAY, N.E. and HEMMINKI, K. (1988). Quantifying the carcinogenicity of antineoplastic drugs. Eur. J. Clin. Oncol., 24:703–711.
KIER, L.D., BRUSICK, D.J., AULETTA, A.E., VON HALLE, E.S., BROWN, M.M., SIMMON, V.F., DUNKEL, V., McCANN, J., MORTELMANS, K., PRIVAL, M., RAO, T.K. and RAY, V. (1986). The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 168:69–240.
KUROKI, T. and MATSUSHIMA, T. (1987). Performance of short-term tests for detection of human carcinogens. Mutagenesis, 2:33–37.
MONTESANO, R., BARTSCH, H., VAINIO, H., WILBOURN, J. and YAMASAKI, H. (eds.). (1986). IARC Scientific Publications No. 83. Long-term and short-term assays for carcinogens: a critical appraisal. Lyon: IARC.
ROSENKRANZ, H.S. (ed.). (1988). Genetic toxicity testing and biomonitoring of environmental or occupational exposure. Mutat. Res., 205.
SHELBY, M.D. (1988). The genetic toxicity of human carcinogens and its implications. Mutat. Res., 204:3–15.
SHELBY, M.D., ZEIGER, E. and TENNANT, R.W. (1988). Commentary on the status of short-term tests for chemical carcinogens. Environ. Mol. Mutagenesis, 11:437–441.
TENNANT, R.W., MARGOLIN, B.H., SHELBY, M.D., ZEIGER, E., HASEMAN, J.K., SPALDING, J., CASPARY, W., RESNICK, M., STASIEWICZ, S., AANDERSON, B. and MINOR, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236:933–941.
TOMATIS, L., BRESLOW, N.E. and BARTSCH, H. (1982). Experimental studies in the assessment of human risk. In: D. Schottenfeld and J.F. Fraumeni, Jr. (eds.)., Cancer Epidemiology and Prevention. W.B. Saunders Company, Philadelphia, London, Toronto, Mexico City, Rio de Janeiro, Sydney, Tokyo, pp. 44–73.
Author information
Authors and Affiliations
Additional information
Presented in part at the European Meeting of the Toxicology Forum, October 12–16, 1987, held in Berlin, FRG (pp. 15–31 of the transcript).
Rights and permissions
About this article
Cite this article
Bartsch, H., Malaveille, C. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph series.. Cell Biol Toxicol 5, 115–127 (1989). https://doi.org/10.1007/BF00122647
Issue Date:
DOI: https://doi.org/10.1007/BF00122647